EMA: Summary report on the EMA workshop on stem cellbased therapies London
02.07.2010
The European Medicines Agency (EMA) assembled for the first time European and international experts
from academia, regulatory authorities (Europe, Japan, United States and others) and pharmaceutical
industry, in a workshop on 10 May 2010, to review opportunities and difficulties in developing stem
cell–based therapies and to discuss regulatory challenges.
The source of the news: http://www.ema.europa.eu/pdfs/conferenceflyers/stemcell_therapies/31929410en.pdf
SciencePharma
